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Introduction
The complex signaling pathways leading to neuronal apoptosis in epilepsy have not been completely elucidated. Seizures stimulate calcium influx, glutamate receptor activa-tion and/or release of death receptor ligands [1] and may provoke neuronal death by mitochondrial [2] and death receptor pathways [3, 4] . The E2F family (E2F1-E2F6) is responsible for regulating cell cycle progression; however, E2F1 is also able to induce cell death through several mechanisms [5] . The transcription factor, E2F1, and the interacting pocket-binding protein, Rb, are implicated in the death of neurons in neurodegenerative disorders [6, 7] . E2F1 protein expression is increased in the neuronal cytoplasm of involved brain regions in HIV encephalitis, simian-immunodeficiency virus (SIV) encephalitis [8] , Alzheimer disease [9] , amyotrophic lateral sclerosis [10] , and Parkinson's disease [11] .
Affected neurons in Parkinson's disease display altered distribution of phosphorylated retinoblastoma protein (Rb) [12] . In amyotrophic lateral sclerosis, E2F1 is redistributed into the cytoplasm of motor neurons and the transcriptional regulator Rb is hyperphosphorylated [10] . The International League Against Epilepsy defines medically intractable epilepsy as the failure of two tolerated, appropriately chosen and used antiepileptic medications schedules (either monotherapy or combination therapy) to achieve sustained seizure freedom [12a] . The expression and distribution of E2F1 and Rb have not been previously investigated in brain tissue of patients with medically intractable temporal lobe epilepsy.
Inflammation leads to apoptosis through induction of inflammatory cytokines and chemokines. Inflammatory cytokines including interleukin-1␤ (IL-1␤) are not constitutively expressed in normal brain [13] but are detected in a wide range of neurodegenerative disorders [14] . Cytokine expression has been noted in autopsy tissues of patients with temporal lobe epilepsy [15] and rodent brain tissues after seizure induction [16] . The cytokine IL-1␤ may induce proapoptotic and excitatory signals, which lead to long-lasting changes in gene transcription [17] . In animal models of epileptogenesis, activation of the IL-1␤ system is associated with neurodegeneration and blood-brain barrier breakdown [18] . Anti-inflammatory drugs are considered for use in epilepsy both for their anticonvulsant activity and modulation of gene transcription [19] . Vagus nerve stimulation has been shown to have immune rebalancing functions which may be related to its antiseizure action [20] . However, expression of IL-1, TNF-alpha and IL-10 in the brain may be associated with cell injury other than that associated with seizures and these cytokines may in certain situations have neuroprotective effects [21, 22] .
Chemokines are chemotactic proteins classified into four subfamilies known as CXC-, CC-, C-, and CXXXCchemokines [23] . In the central nervous system, chemokines have additional functions, including control of neural plasticity by CCL5 [24] , a role of CCL5-CCR5 in inflammation and apoptosis, and a dichotomous role of CXCR4, which has positive neurodevelopmental effects through its ligand SD F-1 [25] and neurotoxic effects mediated by the HIV-1 protein gp120 [26] . Chemokines may lead to neuronal death through E2F1 signaling [27] .
In this study, we examine upstream signals for apoptosis, including inflammatory signals by chemokines, cytokines and cyclooxygenase-2 (COX-2) and the cell cycle transcription factor, E2F1. The results suggest that apoptosis in neurons of patients with medically intractable temporal lobe epilepsy ("TLE neurons") may be induced by a combination of chemotactic and mitogenic stimuli. These findings have implications for tailoring the development of new medical and surgical therapies targeted towards specific chemotactic and mitogenic stimuli of neuronal apoptosis in patients with medically intractable temporal lobe epilepsy.
Materials and methods

Surgical tissues
The Institutional Review Boards at the University of Arizona and UCLA approved the protocol of the study and the Human Consent. The study involved 13 TLE patients, 18-50 years old with the average preoperative seizure frequency ranging from 0.02 to 18 seizures per day (rare seizures, seizure frequency ≤0.1 seizures per day, in 6 patients; frequent seizures, seizure frequency >0.1 seizure per day, in 7 patients), temporal lobe origin of seizures and clinical phenomenology of complex partial seizures. All patients in this study underwent en bloc anterior temporal lobectomy and amygdalohippocampectomy after preoperative planning and seizure focus localization to a single temporal lobe in accordance with previously described technique [28] . Briefly, the anterior temporal lobectomy technique involved en bloc resection of the lateral temporal cortex followed by dissection of superior temporal gyrus white matter using subpial technique, exposure of the temporal horn, and identification of the amygdala and hippocampus using the choroidal fissure as the superior-most landmark for en bloc resection of the hippocampus. The neurosurgical specimens were removed within 30-45 min from the beginning of the operation. Postoperatively, eight patients became seizure-free, 5 significantly improved and one improved in accordance with previously described seizure outcome criteria [28] (Table 1) . Lateral temporal cortical tissues included surgical specimens of one trauma and one brain tumor (glioblastoma multiforme) case, and three postmortem cases of non-epileptic temporal lobe tissues. Samples were split with sterile scalpels in an aseptic environment for processing into 10% buffered formalin, which was kept at room temperature, and O.C.T. compound, which was placed into liquid nitrogen for immediate freezing. Formalin samples were transferred into 70% ETOH the next morning and sent for routine paraffin embedding. Samples were cut at 5 m slices for immunohistochemistry. Frozen blocks were transferred to −80 • C until sectioned at 5 m for immunofluorescence.
Immunohistochemistry (IHC)
IHC was performed using the single or double Envision technique (with rabbit and mouse antibodies) or the LSAB 2 technique (with goat antibody) (both from DAKO, Carpinteria, CA) as previously described [29] . Briefly, the tissue sections were deparaffinized, subjected to antigen retrieval by steam in DAKO antigen retrieval solution, blocked with dual endogenous block solution followed by serum-free protein block solution (both DAKO), stained in the Sequenza apparatus with the primary antibody in the single Envision technique (DAKO) and stained additionally with the second primary antibody in the double Envision technique. The primary antibodies (at 5 or 10 g/ml) were rabbit anti-RANTES (Torrey Pines Biolabs Inc.), mouse-anti-RANTES (BioSource), 
Confocal microscopy
Cryoprotected sections were fixed in 100% acetone, washed with phosphate-buffered saline (PBS), permeabilized with 0.1% Triton in PBS for 10 min, washed again with PBS, blocked with 3% normal goat serum, incubated with primary antibodies (rabbit anti-RANTES and mouse anti-MAP2) followed by incubation with secondary antibodies (anti-mouse ALEXA488 and anti-rabbit ALEXA 594) and DAPI and examined by confocal microscopy as described [30] . (Table 2) RANTES (CCL5) was expressed in patchy fashion in neuronal nuclei (identified by NeuN staining) (Fig. 1A-D ) of all TLE tissues but one (Table 2 ). Nuclear localization of RANTES was confirmed by IHC (Fig. 1B) and confocal microscopy, which showed colocalization of RANTES with the nucleus (Fig. 1C) . Hippocampal TLE tissues were tested in 7 patients and all were positive for nuclear RANTES (Table 2) . RANTES staining was absorbed by RANTES antigen (not shown). Astrocytes did not express RANTES (Fig. 1D) . IP-1␣ (CCL3), MIP-1␤ (CCL4) (Fig. 1  E and F) and MCP-1 (CCL2) (not shown) were expressed in neuronal cytoplasm spreading into the neuropil. Neurons in the control tissues were negative for RANTES (Fig. 1G) . The chemokine receptors CCR1 and CCR5 were expressed in lateral temporal cortical and hippocampal neurons of TLE cases ( Fig. 1I and J) but not in the control tissues (Fig. 1L) .
Results
CC-chemokines RANTES, MIP-1α and MIP-1β and their receptors CCR1 and CCR5 are expressed in TLE neurons
TLE endothelial cells express SDF-1 and IL-6
The TLE neurons expressed the CXCR4 receptor (Fig. 1K) but not its ligand, the chemokine SDF-1 (CXCL12) (Fig. 1H) . Endothelial cells in TLE tissues expressed SDF-1 (Fig. 1H ) and IL-6 (Fig. 2D) , a cytokine probably responsible for induction of SDF-1 [31] .
COX-2 and interleukin-1β expression is non-specific for TLE
In TLE neurons COX-2 expression was cytoplasmic and variable in its intensity, involving either rare neurons ( Fig. 2A) or all neurons in zonal fashion (Fig. 2B) , and while it did not consistently correlate with the frequency of seizures COX-2 expression was strong in the patients #3, #4 and # 7 with rare seizures (Tables 1 and 2 ). Neuronal expression of COX-2 was also noted in the traumatic brain injury tissue (Fig. 2C ). IL-1␤ was expressed by TLE neurons (Fig. 2F ) but not by astrocytes (Fig. 2G ) or neurons in peritumoral tissue (Fig. 2H) . When double-stained, COX-2 and IL-1␤ co-localized in TLE neurons (Fig. 2E) .
Cell cycle proteins and apoptotic markers are expressed in TLE neurons
E2F1 was expressed exclusively in the neuronal cytoplasm of all tested TLE specimens ( Fig. 3E and F) , but not in the trauma case (Fig. 3G ) or control autopsy brain tissues (Table 2) . Phosphorylated Rb was not expressed in any TLE tissue (Fig. 3H) ( Table 2 ). The apoptotic markers, cleaved caspase 3, 8 and 9, were positive in neurons of all tested TLE specimens (Fig. 3B-D) (Table 2 ). Only one TLE specimen showed widespread TUNEL staining of neurons; the remaining specimens were negative (Fig. 3A) .
Perivascular infiltration with macrophages and leakage of blood-brain barrier in TLE
Temporal lobe epilepsy tissues showed perivascular infiltration with macrophages and visible microglia (Fig. 4A and  B) , whereas the trauma tissue showed only microglia but not perivascular macrophages (Fig. 4C) . The TLE tissue showed perivascular fibrinogen leakage (Fig. 4D) . No infiltration by CD3 T or CD20 B cells of TLE tissues was detected (not shown).
Discussion
This study identifies upstream chemokine and cell-cycle protein signals of neuronal apoptosis through immunohistochemistry and confocal microscopy of lateral cortical and hippocampal tissues in patients who have undergone surgical treatment of medically intractable temporal lobe epilepsy (TLE). In this study, we have examined surgical specimens of TLE patients for the expression of chemokines and the transcription factor, E2F1, and neuronal apoptosis. The neurons expressed CC-chemokines but not CXC-chemokines. The salient finding was RANTES expression in the nuclei of TLE neurons but not control neurons. The nuclear localization of RANTES contrasts with the typical cytoplasmic and extracellular distribution of chemokines. Chemokine induction is unlikely a result of surgery because the time from onset to completion of surgical removal of both lateral temporal cortex and hippocampus (30-45 min) was too short for protein expression. After a surgical insult to the mouse brain, MCP-1 induction required at least 3 h and that of RANTES at least 24 h [32] . Furthermore, RANTES does not translocate to the nucleus [33] . Chemokines are chemotactic proteins classified within four sub-families (CXC-, CC-, C-, and CXXXC) [23] which, in the central nervous system, may exert control of neural plasticity (via CCL5) [24] , inflammation and apoptosis (via CCL5-CCR5) and may have positive neurodevelopmental effects (via the SD F-1 ligand) [25] or neurotoxic effects (via the HIV-1 protein gp120) [26] . Chemokines may lead to neuronal death through the E2F1 signaling pathway [27] . CC-chemokines have been shown to be upregulated in the hippocampus in the pilocarpine model of status epilepticus and are implicated in pathological neuroplasticity and neuroinflammation following seizures [34] . The chemokine, RANTES has been implicated in the recruitment of inflammatory cells to the central nervous system in the kanic acid seizure model [35] . In the current study, the chemokine RANTES (CCR5) and other CC-chemokines were expressed in lateral temporal cortical and hippocampal neurons of TLE patients, but not in neurons of control cases. The chemokine RANTES is usually found in cytoplasmic and extracellular locations. However, in TLE neurons, RANTES was displayed in an unusual location, the neuronal nuclei. In surgical specimens of TLE patients in the current study, neurons expressed CC-chemokines, but not CXC-chemokines.
Induction of inflammatory cytokines and chemokines leads to apoptosis. Inflammatory cytokines, such as interleukin 1␤ (IL-1␤), are not usually expressed in normal brain tissue but are demonstrated in a diverse range of neurodegenerative disorders [14] . Cytokine expression has been detected in temporal lobe epilepsy at autopsy [15] and in rodent brain tissues after seizure induction [16] . The cytokine IL-1␤ may 
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induce pro-apoptotic and excitatory signals, which lead to long-lasting changes in gene transcription [17] . IL-1␤ is proconvulsive [36] , has increased expression in the dentate gyrus following lithium-pilocarpine-induced seizures and has been implicated in the pathophysiology of status epilepticus and functional brain impairment after seizures [37] . In the current study, TLE and trauma case neurons strongly expressed IL-1␤ and COX-2. IL-1␤ is induced by pyrogenic signals in the anterior hypothalamus in febrile states. IL-1␤ induction in epilepsy may be due to febrile stimuli and/or ischemic, traumatic or excitotoxic stimuli [19] . IL-1␤ induces inflammatory activation of the brain, as shown in mixed glial/astrocyte cultures where bacterial lipopolysaccharide stimulates IL-1␤ followed by release of prostaglandin E2 and IL-6, and activation of NF-␤B, p38, JNK and ERK1/2 [38] .
In the central nervous system, chemokines and chemokine receptors play crucial developmental functions and modulate the central nervous system for neurorepair and neuroregeneration or inflammation and cell death. Examples of such neuroprotective and neuroregenerative activities include induction of RANTES-responsive genes involved in neuronal survival, neurite outgrowth and synaptogenesis [24] and attraction of neuronal progenitors towards inflammatory stimuli [39] .
Chemokines are small molecules, which diffuse readily from the cytoplasm, thus the restricted nuclear location of RANTES in epileptic neurons belies its chemotactic role. However, another chemokine PESKY/CCL27 has a nuclear translocation residue and, upon nuclear translocation, induces cytoskeletal actin reorganization [35] , which could lead to apoptosis, as is the case in HIV-1 infection [36] . As discussed below, in TLE brains, nuclear RANTES could play a role in neuronal apoptosis because all but one of the examined TLE tissues showed neurons positive for RANTES and activated caspases. RANTES, MIP-1␣/␤ and MCP-1 may have chemotactic function leading to perivascular infiltration by macrophages.
The chemokine, SDF-1, is the ligand for the CXCR4 receptor. SDF-1 itself was expressed only by endothelial cells in the TLE cases but its receptor, CXCR4, was expressed in TLE neurons. Chemokine signaling by HIV-1 through CXCR4 induces neuronal apoptosis [41] . CXCR4 signaling may be pro-apoptotic through activation of E2F1 [27] or antiapoptotic through activation of Akt [42] . Although the role of SDF-1 signaling in epilepsy is unresolved, we speculate that it could be important therapeutically using synthetically modified CXCR4 and CCR5 ligands modulating neuronal survival rather than apoptosis [43] Apoptotic markers (caspase-3, -8, -9) were expressed in lateral temporal cortical and hippocampal neurons of TLE patients but not in neurons of control cases. The cell-cycle regulatory transcription factor E2F1 was found in an abnormal location, exclusively in TLE neuronal cytoplasm but phosphorylated Rb (pRb) was not detected. RANTES has been shown to cause subcellular translocation of E2F1 from neuronal nuclei to the cytoplasm potentially explaining the cytoplasmic localization of E2F1 in neurons of patients with medically intractable temporal lobe epilepsy [44] . However, in the current study, this cytoplasmic localization of E2F1 was not associated with the previously reported concurrent observation of increased phosphylorated Rb [44] , suggesting a potentially alternate and as yet unidentified mechanism for the subcellular translocation of E2F1 in human temporal lobe epilepsy. The mechanism by which cytoplasmic E2F1 produces apoptosis in temporal lobe epilepsy is not known. However, E2F1 has been shown to induce apoptosis independent of its transcriptional activity [45] . Specifically, E2F1 can induce apoptosis by a death receptor-dependent mechanism through downregulating TRAF2 protein levels [45] . TRAF proteins are intracellular signal transducers for several superfamilies of immune receptors [45] . TRAF2 interacts with TNF receptors mediating the survival of the receptors [45] . TRAF2, which E2F1 downregulates, is required for protection against TNF-induced apoptosis [46] . While the transcription factor E2F1 is known for its interaction with pRb, particularly in controlling cell proliferation, E2F1 also appears to have a pivotal role in regulating apoptosis in the absence of phosphylorated Rb [47] . For instance, in certain breast cancer cell lines which lack pRb, E2F1 overexpression results in apoptosis [47] . E2F family transcription factors are crucial in the induction of aberrant cell cycle and neuronal apoptosis [48] . Phosphorylation of Rb releases E2F1 from a complex with Rb and activates cell cycle programming [49] . E2F1 and molecules that either regulate E2F activity or that are transcriptional targets of E2F, in particular P-Rb and p53, are induced in diverse neurodegenerative diseases, such as SIV encephalitis [50] and Parkinson's disease [11, 12] . E2F1 is involved in chemokine related neurotoxicity [27] , through mechanisms which upregulate proteins Cdc2 and Puma [51] . For example, deletion of puma appears to protect hippocampal neurons in a status epilepticus model [52] . Specifically, neuronal death is reduced by approximately 50% in the hippocampus of puma-deficient mice [52] . Supporting the concept that apoptotic pathway activation is a trigger of epileptogenesis, data have been reported which show that genetic deletion of the proapoptotic protein, puma, acting acutely influences neuronal death and subsequently alters the phenotype of epilepsy in the long-term [53] . In a rodent model, in comparison to puma-expressing mice, puma-deficient mice had significantly smaller hippocampal lesions following status epilepticus [53] . Long-term EEG recording detected an approximately 60% reduction in the frequency of epileptic seizures in puma-deficient mice compared to puma-expressing mice [53] .
RANTES stimulates increased cytoplasmic expression of E2F1 and nuclear localization of the hyperphosphorylated retinoblastoma susceptibility gene product (ppRb) [54] . The balance of cytoplasmic and nuclear location of E2F1 may play a role in pathological role of E2F1 in neurodegenerative disorders [55] . While RANTES alone has been shown to induce apoptosis through activation of caspase-9, caspase-3, release of cytochrome c and poly(ADP-ribose) polymerase cleavage, there is evidence that IFN-gamma stimulates RANTES which in turn produces apoptosis via stimulation of caspase-3 and caspase-9 [56, 57] . Production of IF-N gamma has been shown to result from Con Astimulated splenocytes in left side kindled rats with temporal lobe seizures [58] . Therefore, future research is warranted to investigate the complex interactions involving IFN-gamma, RANTES, caspase-3, caspase-9 and their roles in neuronal apoptosis in temporal lobe epilepsy. If E2F1 is involved in the pathogenesis of neuronal apoptosis in TLE, E2F1 blockade might be beneficial in TLE as has been shown in 1-methyl-4-phenyl 1,2,3,6 tetrahydropyridine model of Parkinson's disease [11] . Based on these considerations, neuroprotective drugs for epileptic neurons should be sought among anti-inflammatory drugs, such as flavonoids [59] , neurotrophic factors [60] , small molecular inhibitors of RANTES signaling through Met-RANTES/CC chemokine ligand 5 (CCL5) [61] , CCR5 antagonists, such as the Merck's compound 167 (CMPD 167) [62] , and caspase inhibitors [63, 64] . The role of cytoplasmic E2F1 in neurodegenerative diseases, such as HIV encephalitis, SIV encephalitis, Alzheimer disease, Parkinson disease, Huntington disease, and amyotrophic lateral sclerosis, is not understood but, as suggested by Jordan-Sciutto [65] , the insight into cytoplasmic effects of E2F1 could lead to novel and unique therapeutic opportunities in neurodegenerative diseases.
The results of this study suggest that chemotactic and mitogenic stimuli of neuronal apoptosis are expressed in both cortical and hippocampal tissues in patients with medically intractable temporal lobe epilepsy. These findings may have implications for the development of new medical and surgical therapies for TLE. Recent evidence suggests that increasing resection of temporal lobe tissue beyond selective hippocampectomy to include entorhinal and lateral temporal cortex may optimize seizure outcome in TLE [66] [67] [68] . Improved seizure outcome with more extensive resection of hippocampus with lateral temporal cortex may be a result of increased removal of diseased neuronal populations affected by inflammation and apoptosis. Anti-inflammatory drugs are considered for use in epilepsy both for their anticonvulsant activity and modulation of gene transcription [19] . Vagus nerve stimulation has been shown to have immune rebalancing functions which may be related to its antiseizure action [20] . Inhibition of neuronal inflammation and apoptosis may provide a new paradigm for development of medical and surgical strategies including neuromodulation of both the central and peripheral nervous system.
Conclusion
In this study, we have examined surgical specimens of TLE patients for the expression of chemokines and the transcription factor, E2F1, and neuronal apoptosis. The results of this study suggest that apoptosis in neurons of patients with medically intractable temporal lobe epilepsy may be induced by a combination of chemotactic and mitogenic stimuli. The cytoplasmic effects of E2F1 and nuclear effects of RANTES might have novel roles in apoptosis of TLE neurons and indicate a need to develop new neuroprotective strategies against apoptotic signaling by these molecules. Both RANTES and E2F1 signaling are upstream from caspase activation, thus the authors hypothesize that medical and/or surgical therapeutic antagonists of RANTES and/or E2F1 blockade might be neuroprotective for patients with medically intractable temporal lobe epilepsy. Temporal cortical, hippocampal and vagus nerve stimulation should be evaluated for their neuromodulatory effects in blocking neuronal RANTES and E2F1 expression. The results offer a new paradigm for development of medical and surgical therapy, including resective surgery and neuromodulation, based on removal and/or inhibition of chemotactic and mitogenic stimuli of neuronal apoptosis in patients with medically intractable temporal lobe epilepsy.
